10-K Decoder · All companies

Nuvation Bio Inc.

NUVB · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$62.9M$7.87M+699%
Operating income−$213M−$593M+64.0%
Net income−$205M−$568M+64.0%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 4, 2026

$Q3 2026Year earlierChange
Revenue$45.0M$13.1M+244%
Operating income−$42.2M−$56.4M+25.2%
Net income−$41.9M−$55.8M+24.9%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Nuvation Bio's revenue in FY2025?
$62.9M in FY2025 (Fiscal year ended Dec 31, 2025), +699% vs $7.87M a year earlier, per its 10-K filed Mar 2026.
Was Nuvation Bio profitable in FY2025?
No: net income was −$205M and operating income −$213M in FY2025.
What was Nuvation Bio's revenue in Q3 2026?
$45.0M (+244% vs a year earlier), per its Form 10-Q filed Nov 4, 2026.